Financial Summary (All financials)
| In millions, except per share items | Jan-01-23 | Jan-02-22 | Jan-03-21 | Dec-29-19 | Dec-30-18 |
| Revenues | 1,060.1 | 783.3 | 844.8 | 1,198.3 | 912.3 |
| Revenue growth | 35.3% | -7.3% | -29.5% | 31.3% | |
| Cost of goods sold | 1,108.1 | 812.3 | 854.6 | 1,200.6 | 1,007.5 |
| Gross profit | -47.9 | -29.0 | -9.8 | -2.3 | -95.2 |
| Gross margin | -4.5% | -3.7% | -1.2% | -0.2% | -10.4% |
| Selling, general and administrative | 100.5 | 88.8 | 86.2 | 96.9 | 82.0 |
| Research and development | 49.7 | 46.5 | 34.2 | 37.0 | 50.0 |
| EBIT | -207.2 | -180.8 | -133.4 | -141.5 | -584.9 |
| EBIT margin | -19.5% | -23.1% | -15.8% | -11.8% | -64.1% |
| Pre-tax income | -225.9 | -239.1 | -125.7 | -163.4 | -602.2 |
| Income taxes | 32.2 | 0.2 | 12.1 | 10.1 | -1.1 |
| Tax rate | | | | | 0.2% |
| Net income | -267.4 | -254.5 | -142.6 | -183.1 | -603.8 |
| Net margin | -25.2% | -32.5% | -16.9% | -15.3% | -66.2% |
| |
| Diluted EPS | ($6.54) | ($6.79) | ($5.82) | ($8.61) | ($28.39) |
| Shares outstanding (diluted) | 40.9 | 37.5 | 24.5 | 21.3 | 21.3 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|